Quick Answer
DarioHealth Corp. reported Cash and Equivalents of $21.80 million for fiscal year 2025.
DarioHealth Corp. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $21.80M | -21.5% |
| 2024 | $27.76M | -24.5% |
| 2023 | $36.80M | -25.4% |
| 2022 | $49.36M | +37.8% |
| 2021 | $35.81M | +25.2% |
| 2020 | $28.59M | +40.2% |
| 2019 | $20.39M | +85.5% |
| 2018 | $11.00M | +195.8% |
| 2017 | $3.72M | +240.2% |
| 2016 | $1.09M | -59.1% |
| 2015 | $2.67M | +83.8% |
| 2014 | $1.45M | -35.8% |
| 2013 | $2.26M | +84.0% |
| 2012 | $1.23M | +35.3% |
| 2011 | $908.8K | — |
| 2011 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.91M | +105.2% | +45.3% |
| June 30, 2025 | $21.95M | -4.3% | -21.2% |
| March 31, 2025 | $27.85M | -19.0% | +0.3% |
| December 31, 2024 | $27.76M | -24.5% | +78.6% |
| September 30, 2024 | $15.55M | -64.6% | -32.2% |
| June 30, 2024 | $22.94M | -56.4% | -33.3% |
| March 31, 2024 | $34.37M | -11.4% | -6.6% |
| December 31, 2023 | $36.80M | -25.4% | -16.1% |
- DarioHealth Corp. showed a decrease of -21.5% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from DarioHealth Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: